CLDN2 and malignant colon neoplasm: Moreover, recent evidence demonstrates that claudin-2 is involved in many signaling pathways, including vitamin D receptor, EGFR, and JNK signaling pathways, and it contributes to inflammatory bowel disease and colon cancer [2], [3], [4], [5], [6].